USPTO serial 97107129
THE POWER OF CERTAINTY
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- KETCHUM, BRENDAN J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with THE POWER OF CERTAINTY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David M. Kramer
David M. Kramer Buchanan Ingersoll & Rooney, P.C.1700 K Street N.W.Suite 300Washington, DC 20006Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for use in collecting, managing and analyzing quality of life, subjective symptom, and similar self-observation data self-reported by patients in pharmaceutical clinical trials; downloadable computer software for the collection, interpretation, evaluation, auditing, management, processing, tracking and viewing of data in the field of clinical trials; downloadable computer software for calibrating and managing medical instruments used in clinical trials; computer software, namely, downloadable interactive voice response software with a computer or telephone interface for the collection, interpretation, evaluation, auditing, management, processing, tracking, and viewing of data in the fields of medical technology, healthcare, and clinical trials; electronic docking stations for the collection, interpretation, evaluation, auditing, management, processing, tracking, and viewing of data in the fields of medical technology, healthcare, and clinical trials | ACTIVE | — |
| 010 | Medical devices for the respiratory system, namely, for measuring, monitoring, collecting, recording, transmitting, and evaluating data regarding expiratory flow, respiratory symptoms, and respiratory medication consumption; medical devices for measuring, monitoring, collecting, recording, transmitting, and evaluating data concerning expiratory flow and cardiopulmonary behavior; portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; medical apparatus and equipment for examining lung function and parts therefor; medical electronic apparatus and equipment, namely, spirometers, pulse oximeters, and electrocardiographs; integrated medical research systems comprising wearable devices with sensors, namely, accelerometers, gyroscopes, and magnetometers, to monitor the physical movements of an individual wearing the device and downloadable computer software and monitors used during the process of monitoring the movement of an individual | ACTIVE | — |
| 035 | Computerized database management services in connection with clinical trials of medical and clinical diagnostic products; business consulting services in relation to clinical data and regulatory management for healthcare industry organizations, namely, biopharmaceutical organizations, contract research organizations, medical device companies, and hospitals; business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; providing independent review of clinical trials for business purposes; database management services, namely, aggregating and organizing data in connection with clinical trials of medical and clinical diagnostic products | ACTIVE | — |
| 041 | Business training services, namely, scientific and regulatory leadership development training for healthcare industry organizations, namely, biopharmaceutical organizations, contract research organizations, medical device companies, and hospitals; training and development in the field of conducting clinical trials, namely, conducting seminars and workshops in the field of clinical trials; training in the field of computer software support, namely, conducting seminars and workshops in the field of software support in the fields of medical technology, healthcare, and clinical trials | ACTIVE | — |
| 042 | Data automation and collection service using proprietary software to evaluate, analyze, and collect data in the fields of medical technology, healthcare, and clinical trials; consulting services in the field of clinical trials of medical and clinical diagnostic products; design and development of computer software for collecting, storing, managing, analyzing, and reporting on healthcare data and clinical trial data; providing temporary use of non-downloadable computer software for collecting, storing, managing, analyzing, and reporting on healthcare data and clinical trial data; design and development of computer software for data analytics, data visualization, and data workflow in the healthcare and pharmaceutical industries; providing temporary use of non-downloadable computer software for data analytics, data visualization, and data workflow in the healthcare and pharmaceutical industries; providing temporary use of non-downloadable software for use in screening and monitoring patients for suicide risk; providing temporary use of non-downloadable software for measuring expiratory flow volume and monitoring, collecting, and evaluating expiratory flow data; application service provider services featuring software for the collection, management and reporting by others of clinical research and marketing; providing a database featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing a website featuring medical and scientific research information pertaining to clinical trials of pharmaceuticals; providing medical and scientific research information in the field of clinical trials; laboratory services, namely, imaging core lab services; technical consulting services in the field of clinical trials; providing an on-line computer database in the field of clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by eResearchTechnology, Inc.
- Other trademarks owned by eResearchTechnology, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named THE POWER OF CERTAINTY
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 14, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 1, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 1, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 1, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 9, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 8, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 8, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 8, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 22, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Nov 22, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 22, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 22, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 22, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 10, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 28, 2023 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Aug 28, 2023 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Aug 28, 2023 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jun 30, 2023 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jan 31, 2023 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 3, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 3, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 14, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 29, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 29, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 29, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 29, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 29, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 25, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 18, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 3, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 23, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 22, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 22, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 12, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 15, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 6, 2021 | NWAP | NEW APPLICATION ENTERED | — |